ACCUiN Next Generation Fusion Gene Analysis Panel
ALK, FGFR1, FGFR2, FGFR3, MET, NTRK1, NTRK2, NTRK3, RET, and ROS1 gene fusions
.png)
ACCUiN Next Generation Fusion Gene Analysis Panel
Product Introduction
ACCUiN Next Generation Fusion Gene Analysis Panel is a qualitative detection designed using reverse transcription and Multiplex polymerase chain reaction (Multiplex PCR), requiring next-generation sequencing system (NGS) to detect whether test samples have specific gene fusion variants. ACCUiN Next Generation Fusion Gene Analysis Panel can be used to detect fusion variants in malignant solid tumor tissues with ALK (NM_004304), FGFR1 (NM_023110), FGFR2 (NM_022970), FGFR3 (NM_000142), MET (NM_001127500), NTRK1 (NM_002529), NTRK2 (NM_006180), NTRK3 (NM_002530), RET (NM_020975), and ROS1 (NM_002944). ACCUiN Next Generation Fusion Gene Analysis Panel has passed quality validation and functional verification to ensure performance stability and reproducibility. ACCUiN Next Generation Fusion Gene Analysis Panel can provide at least 48 detection reactions.
Specifications
- CGF-48A: Index 1-24
- CGF-48B: Index 25-48
- CGF-48C: Index 49-72
- CGF-48D: Index 73-96
- Reaction quantity: 48 reactions
- Detection target: ALK, FGFR1, FGFR2, FGFR3, MET, NTRK1, NTRK2, NTRK3, RET, ROS1 gene fusions
- Detection method: Multiplex PCR + NGS
- Sample type: Malignant solid tumor tissue
Simple Flowchart
.png)

.png)